Table 4.
Factor | Adjusted Odds Ratio (95% CI) | P value |
---|---|---|
Age, 46–65 vs 18–45 years | 1.199 (1.104 to 1.302) | < 0.0001 |
Age, > 65 vs 18–45 years | 1.034 (0.957 to 1.116) | 0.3961 |
Male vs Female | 1.999 (1.907 to 2.095) | < 0.0001 |
Non-White vs White | 1.226 (1.166 to 1.289) | < 0.0001 |
Admitted to ICU vs No | 2.142 (2.036 to 2.253) | < 0.0001 |
Had urine catheters vs No | 1.237 (1.164 to 1.314) | < 0.0001 |
Had urinary surgery vs No | 1.428 (1.333 to 1.529) | < 0.0001 |
Escherichia coli vs Other | 2.026 (1.9 to 2.159) | < 0.0001 |
Klebsiella pneumoniae vs Other | 1.447 (1.333 to 1.571) | < 0.0001 |
Acinetobacter baumannii vs Other | 0.587 (0.342 to 1.005) | 0.0524 |
Pseudomonas aeruginosa vs Other | 0.628 (0.554 to 0.712) | < 0.0001 |
Stenotrophomonas maltophilia vs Other | 0.349 (0.18 to 0.675) | 0.0018 |
CS vs CR | 1.754 (1.484 to 2.073) | < 0.0001 |
Onset HA (after 3 days) vs CA (within 3 days) | 0.229 (0.209 to 0.252) | < 0.0001 |
CA Community acquired, CR Carbapenem resistant, CS Carbapenem susceptible, HA Hospital acquired, ICU Intensive care unit, UTI Urinary tract infection